IFAM
TXG icon

Institutional & Family Asset Management’s 10x Genomics TXG Stock Holding History

Institutional & Family Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-68
Closed -$2.48K – 758
2022
Q4 		$2.48K Sell
68
-122
-64% -$3.99K ﹤0.01% 541
2022
Q3 		$5K Hold
190
– – ﹤0.01% 495
2022
Q2 		$9K Hold
190
– – ﹤0.01% 407
2022
Q1 		$14K Buy
190
+39
+26% +$3.41K ﹤0.01% 405
2021
Q4 		$22K Buy
+151
New +$23.1K ﹤0.01% 358

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Institutional & Family Asset Management's TXG Position: Q1 2023 in Review

Institutional & Family Asset Management sold out of 10x Genomics (TXG) in Q1 2023, closing a stake of 68 shares — an estimated $2.48K sold.

Institutional & Family Asset Management first reported a position in TXG in Q4 2021 and held it in 5 quarters. The position peaked at $22K in Q4 2021. 258 funds tracked by Wall St. Rank hold TXG as of Q1 2023.

  • Institutional & Family Asset Management reported no remaining 10x Genomics position as of Q1 2023 after selling out during the quarter.
  • Institutional & Family Asset Management sold 68 10x Genomics shares in Q1 2023, an estimated $2.48K.
  • Institutional & Family Asset Management first reported a position in 10x Genomics in Q4 2021 and held it in 5 quarters.
  • Institutional & Family Asset Management's 10x Genomics position peaked at $22K in Q4 2021.
  • 258 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2023.

Based on Institutional & Family Asset Management's 13F filing for Q1 2023, filed 9 May 2023.